High-dose ursodeoxycholic acid increases risk of adverse outcomes in patients with early stage primary sclerosing cholangitis
2011 ◽
Vol 34
(10)
◽
pp. 1185-1192
◽
Keyword(s):
Keyword(s):
Keyword(s):
2012 ◽
Vol 35
(4)
◽
pp. 451-457
◽
2011 ◽
Vol 106
(9)
◽
pp. 1638-1645
◽
2001 ◽
Vol 96
(5)
◽
pp. 1558-1562
◽
Keyword(s):
2007 ◽
Vol 9
(1)
◽
pp. 54-59
◽
Keyword(s):